PEG Metabolite Derivatization for LC/MS Sensitivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and quantifying polyethylene glycol (PEG) metabolites and breakdown products lack sensitivity, accuracy, and reproducibility, particularly in assessing toxicity and distribution within the body or in PEG-containing products.
Innovation Solution
A method involving the reaction of PEG metabolites with pentafluorobenzoyl chloride in the presence of an aqueous hydroxide salt, followed by liquid chromatography and mass spectrometry (LC/MS) analysis, to produce and detect pentafluorobenzoate ester derivatives, enhancing sensitivity and reproducibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used for PEG metabolites, then the detection can be performed with simple procedures, but the sensitivity and accuracy are insufficient
Solution Approach 1:
The patent applies preliminary action by performing derivatization of PEG metabolites with pentafluorobenzoyl chloride before analysis. This pre-treatment step converts the metabolites into more detectable forms, enhancing sensitivity without requiring complex instrumentation. The derivatization occurs in advance, allowing the subsequent LC/MS analysis to be more sensitive and accurate.
Solution Approach 2:
The patent uses pentafluorobenzoyl chloride as an intermediary substance that mediates between the PEG metabolites and the detection system. This derivatizing agent acts as a bridge, transforming the metabolites into pentafluorobenzoate ester derivatives that are more amenable to sensitive detection by LC/MS, thereby improving measurement precision without directly modifying the detection instrument.
2Measurement precision
If conventional quantification methods are used, then the assay procedure remains simple, but the accuracy and reproducibility are poor
Solution Approach 1:
The patent applies parameter changes by modifying the chemical parameters of the PEG metabolites through derivatization. By changing the chemical structure to pentafluorobenzoate ester derivatives, the metabolites acquire properties that enhance their detectability and quantifiability by LC/MS, improving accuracy and reproducibility while maintaining a relatively straightforward assay procedure.
Solution Approach 2:
The quantification process benefits from preliminary derivatization action, where the metabolites are chemically transformed before analysis. This pre-treatment ensures that the subsequent LC/MS quantification operates on optimized substrates, leading to better accuracy and reproducibility without requiring complex post-processing or multiple analysis steps.
3Measurement precision
If direct LC/MS analysis is performed on PEG metabolites, then the analysis is straightforward, but the detection sensitivity at low concentrations is insufficient
Solution Approach 1:
The patent introduces pentafluorobenzoyl chloride as an intermediary that facilitates the detection of PEG metabolites at low concentrations. This derivatizing agent acts as a mediator that enhances the signal properties of the metabolites, making them detectable by LC/MS at trace levels that would otherwise be undetectable with direct analysis.
Solution Approach 2:
The patent changes the physical-chemical parameters of the PEG metabolites by converting them to pentafluorobenzoate ester derivatives. This parameter change enhances properties such as volatility, thermal stability, and ionization efficiency, thereby improving detectability and sensitivity in LC/MS analysis without requiring complex sample preparation or instrumentation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the sensitive and accurate detection and quantification of ethylene glycol and diethylene glycol at low concentrations, improving the assessment of PEG toxicity and distribution within individuals and in PEG-containing products.
Implementation Method 1
The sample is combined together with aqueous pentaflurobenzoyl chloride in the presence of an aqueous hydroxide containing salt thus producing an aqueous solution, which comprises a pentafluorobenzoate ester derivative
Implementation Method 2
A liquid phase supernatant is separated from the aqueous solution, and the supernatant is analyzed using liquid chromatography
Implementation Method 3
the supernatant is analyzed using liquid chromatography and mass spectrometry (LC/MS) to both detect and quantify the pentafluorobenzoate ester derivative
Data Source
AI summary
Disclosed herein are compounds and methods for identifying and quantifying a metabolite or breakdown product of PEG. A sample may be assayed for PEG metabolites or breakdown products using liquid chromatography combined with mass spectrometry. Derivatization of the PEG metabolites or breakdown products within the sample with pentaflurobenzoyl chloride in conjunction with negative chemical ionization mode liquid chromatography optimizes the assay.